Literature DB >> 9822060

Hemorrhagic complications of anticoagulant treatment.

M N Levine1, G Raskob, S Landefeld, C Kearon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9822060     DOI： 10.1378/chest.114.5_supplement.511s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  19 in total

1.  Thromboprophylaxis after replacement arthroplasty.

Authors:  D P Thomas
Journal:  BMJ       Date:  2001-03-24

Review 2.  Use of oral anticoagulants in older patients.

Authors:  J L Sebastian; D D Tresch
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

3.  Inferior vena cava filtration in the management of venous thromboembolism: filtering the data.

Authors:  Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

4.  Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.

Authors:  Stephen E Kimmel; Benjamin French; Jeffrey L Anderson; Brian F Gage; Julie A Johnson; Yves D Rosenberg; Nancy L Geller; Scott E Kasner; Charles S Eby; Jungnam Joo; Michael D Caldwell; Samuel Z Goldhaber; Robert G Hart; Denise Cifelli; Rosemary Madigan; Colleen M Brensinger; Suzanne Goldberg; Robert M Califf; Jonas H Ellenberg
Journal:  Am Heart J       Date:  2013-07-12       Impact factor: 4.749

5.  Evaluation of bleeding rates in renal transplant patients on therapeutic intravenous heparin.

Authors:  Theresa Ringenberg; Heather Desanto; Yekaterina Opsha; Jennifer Costello; Daryl Schiller
Journal:  Hosp Pharm       Date:  2013-12

Review 6.  Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation.

Authors:  Bob A J van Deelen; Patricia M L A van den Bemt; Toine C G Egberts; Annelies van 't Hoff; Huub A A M Maas
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 7.  Anticoagulant therapy in special circumstances.

Authors:  T G DeLoughery
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

8.  Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients.

Authors:  W Streif; G Goebel; A K C Chan; M P Massicotte
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

9.  The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom.

Authors:  Jennifer Hollowell; Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis Alberto García-Rodríguez
Journal:  Br J Gen Pract       Date:  2003-04       Impact factor: 5.386

Review 10.  The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism.

Authors:  Paul Alexander Kyrle; Sabine Eichinger
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.